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Viral replicationthan three quarters of their coding capacity to encode two large polyproteins (1a
and 1ab polyproteins), which are proteolytically processed into 15–16mature, nonstructural replicase proteins
(nsp1 to 16). These cleavage products are believed to play essential roles in replication of the giant RNA genome
of ∼30 kb and transcription of a nested set of 5 to 9 subgenomic RNA species by a unique discontinuous
transcription mechanism. In this report, one of these replicase proteins, nsp9 of the coronavirus infectious
bronchitis virus (IBV) is systematically studied using both biochemical and reverse genetic approaches. The
results showed that substitution mutation of a conserved Gly (G98) residue in the C-terminal α-helix domain
with an Asp greatly destabilized the IBV nsp9 homodimer and abolished its RNA-binding activity. Introduction
of the same mutation into an infectious IBV clone system showed that the mutation totally abolishes the
transcription of subgenomic RNA and no infectious virus could be recovered. Mutation of a semi-conserved Ile
(I95) residue in the same region showed moderately destabilizing effect on the IBV nsp9 homodimer but
minimal effect on its RNA-binding activity. Introduction of the mutation into the IBV infectious clone system
showed recovery of a mutant virus with severe growth defects, supporting that dimerization is critical for the
function of this replicase protein. Meanwhile, mutations of some positively charged residues in the β-barrel
regions of the IBV nsp9 protein signiﬁcantly reduced its RNA-binding activity, but with no obvious effect on
dimerization of the protein. Introduction of these mutations into the viral genome showed only mild to
moderate effects on the growth and infectivity of the rescued mutant viruses.
© 2008 Elsevier Inc. All rights reserved.Introduction
Coronavirus is a family of RNA viruses with the largest RNA
genome known so far. In cells infected with coronavirus, a nested set
of genomic and subgenomic RNA species is produced and used for
translation of viral structural and nonstructural proteins. Among these
proteins, the 1a and 1ab polyproteins are post-translationally
processed to smaller, mature proteins (Ziebuhr et al., 2000; Ziebuhr,
2005). It is generally believed that replication of the large RNA genome
and transcription of a nested set of 5 to 8 subgenomic RNA species are
carried out by these replicase proteins. However, the exact functions
of individual replicase proteins are largely unknown. In recent years,
determination of the crystal structures of some of these proteins,
including the proteinase domain of nsp3, nsp5, nsp7 and 8, nsp9,
nsp10 and nsp15, led to the revelation of many important functions for
these proteins (Saikatendu et al., 2005; Ratia et al., 2006; Peti et al.,
2005; Zhai et al., 2005; Anand et al., 2002, 2003; Yang et al., 2003;
Egloff et al., 2004; Sutton et al., 2004; Su et al., 2006; Joseph et al.,
2006; Ricagno et al., 2006), but most of these functions are notl rights reserved.rigorously tested in a biologically relevant system. In this study,
residues critical for dimerization and the RNA-binding activity of nsp9
protein from coronavirus infectious bronchitis virus (IBV) were
systematically studied bymutagenesis, based on the structural studies
of SARS-CoV nsp9 protein.
IBV is a group 3 coronavirus. Its genome contains a 27.6 kb single-
stranded, positive-sense RNA. In the virus-infected cells, six mRNA
species, including the genome-length mRNA 1 and ﬁve subgenomic
mRNAs (mRNA 2–6), are produced, and each mRNA species possesses
a 64 nucleotides leader sequence derived from the 5′-end of the
genome (Boursnell et al., 1987). Subgenomic mRNAs 2, 3, 4, and 6
encode the four structural proteins, i.e., spike glycoprotein (S),
envelope protein (E), membrane protein (M) and nucleocapsid protein
(N). The 5′-two-third region of mRNA 1 encodes the 1a and 1ab
polyproteins, which are proteolytically cleaved by two virus-encoded
proteinases, the papain-like and 3C-like proteinases, into at least 15
nonstructural proteins (nsp2–nsp16) (Lim and Liu, 1998a, 1998b; Lim
et al., 2000; Liu et al., 1995, 1997, 1998; Ng and Liu, 1998, 2000, 2002;
Xu et al., 2001).
A cluster of small proteins, i.e., nsp7, nsp8, nsp9 and nsp10, is
located at the C-terminal region of the la polyprotein. The functional
roles of these proteins in coronavirus RNA replication and transcription
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SARS-CoV nsp8 protein was recently shown to have a non-canonical
RNA-dependent RNA polymerase (RdRp) activity (Imbert et al., 2006).
Most of the replicase products could be assembled into a membrane-
associated viral replication/transcription complex (Sims et al., 2000;
Gosert et al., 2002; Prentice et al., 2004; Shi et al., 1999; Bost et al.,
2000; Masters 2006; Brockway et al., 2003).
Determination of the crystal structure of SARS-CoV nsp9 protein
shows that it forms a homodimer (Egloff et al., 2004; Sutton et al.,
2004). Searching for structural homology between SARS-CoV nsp9 and
other RNA binding proteins suggests that the SARS-CoV nsp9 protein is
a nucleic acid-binding protein and has nonspeciﬁc RNA-binding
activity (Egloff et al., 2004). Biophysical evidence has also shown an
interaction between SARS-CoV nsp9 and nsp8 proteins (Sutton et al.,
2004). Based on sequence comparison, a number of evolutionarily
conserved amino acid residues in different domains of the IBV nsp9
protein were systematically mutated to assess their roles in viral
replication and infectivity by introducing into an infectious cDNA clone
system derived from the genomic RNA of IBV. Subsequently, dimeri-Fig. 1.Mutational analysis of the IBV nsp9 protein. (a) Structure-based alignment of coronavi
based on the structure of SARS-CoV nsp9 protein. Sequences of IBV (infectious bronchitis viru
MHV (Murine Hepatitis Virus, strain 1, AAA46439); TGEV (Porcine Transmissible Gastroenter
from GenBank. The identical amino acid residues in all eight coronavirus species are marked
60% are marked in yellow. The amino acid residues chosen for mutational analysis in this stu
Also shown is the summary of virus recovery from wild type and mutant transcripts.zation and the RNA-binding activity of the puriﬁed wild type and
mutant IBV nsp9 protein were studied by immunoprecipitation, gel
ﬁltration, chemical cross linking and Northwestern blotting. These
studies led to the identiﬁcation of amino acid residues essential for
dimerization and the RNA-binding activity of IBV nsp9 protein. This
study thus presents biochemical and genetic evidence that directly
links dimerization and the RNA binding activity of the coronavirus
nsp9 protein to virus replication and infectivity in cultured cells. This
information would be of help in design of preventive and treatment
approaches against coronavirus infection.
Results
Introduction of single amino acid substitutions into the IBV genome and
analysis of their effect on the replication and infectivity of IBV
Multiple alignment of the nsp9 sequences from IBV (accession No.
NP-040829) and SARS-CoV (accession No. AY291315) shows that the
two proteins share 70% similarity at the amino acid level (Fig. 1a).rus nsp9 protein. Secondary structure elements are labeled above the sequence for IBV,
s, strain Beaudette, NP_040838); H-CoV (Human Coronavirus, strain HKU1, YP_173242);
itis Virus, strain RM4, AAG30228); and SARS (SARS-Coronavirus, 1SSK_A) were obtained
in red, the residues for which conservation is above 70% are marked in blue and above
dy are boxed. (b) Diagram showing the mutations introduced into the IBV nsp9 protein.
Fig. 2. Analysis of the growth properties of wild type, and I95A, I95N and G98A mutant
viruses. (a) Plague sizes (upper panels) and growth curves (lower panel) of wild type
and I95A, I95N and G98A mutant viruses. Monolayers of Vero cells on a 6-well plate
were infected with 100 μl of 1000-fold diluted virus stock and cultured in the presence
of 0.5% carboxymethy cellulose at 37 °C for 3 days. The cells were ﬁxed and stained with
0.1% toluidine. Vero cells were infected with wild type and mutant viruses, and
harvested at 0, 4, 8, 12, 16, 24, 30 and 36 h post-inoculation, respectively. Viral stocks
were prepared by freezing/thawing of the cells three times and TCID50 of each viral
stock was determined by infecting ﬁve wells of Vero cells on 96-well plates in triplicate
with 10-fold serial dilution of each viral stock. (b) Analysis of RNA replication in cells
electroporated with wild type and G98D mutant transcripts. Total RNA was prepared
from Vero cells electroporated with in vitro synthesized full-length transcripts three
days post-electroporation. Regions corresponding to nucleotides 14,931–15,600 of the
positive (+) and negative (−) sense IBV genomic RNA were ampliﬁed by RT-PCR and
analyzed on 1.2% agarose gel (lanes 2–3 and 5–6). The negative sense, subgenomic
mRNA 4 was also ampliﬁed and analyzed (lanes 4 and 7). Lane 1 shows DNA markers.
Numbers on the left indicate nucleotides in bases.
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identify amino acid residues critical for the dimerization and the RNA-
binding activity of the protein. The effect of these mutations on the
infectivity and replication of IBV was studied by using an infectious
IBV cloning system.
Nine point mutations, K10A, Y31A, K51A, Y87A, K90A, I95A, I95N,
G98A and G98D (Fig. 1a), were made and introduced separately into
the infectious IBV clone. The in vitro transcribed full-length RNA
derived from wild type and the mutant constructs were generated by
in vitro transcription using the T7 RNA polymerase in the presence of a
cap analog. Electroporation of wild type RNA transcripts together with
an RNA fragment covering the N protein region into Vero cells showed
the formation of massive cytopathic effect (CPE) at 2 days post-
electroporation (Fig. 1b and data not shown). Similarly, typical CPEs
were observed in cells transfected with mutant transcripts derived
from K10A, Y31A, K51A, K90A, I95A, and G98A constructs at 2 days
post-electroporation and recombinant viruses were recovered (Fig.
1b). In cells electroporatedwith the I95N transcripts, a typical CPEwas
observed at 3 days post-electroporation (Fig. 1b). Re-infection of fresh
Vero cells with medium collected from total cell lysates prepared by
freezing and thawing cells transfected with these mutant transcripts
showed the formation of typical CPE, indicating that the mutant
viruses rescued from the initially transfected cells maintain infectivity
in subsequent passages.
In contrast, no CPE formation was observed in cells transfected
with transcripts derived from Y87A and G98Dmutant constructs up to
5 days post-electroporation in four repeated experiments (Fig. 1b).
Subsequent infection of fresh cells with cell lysate preparations by
freezing and thawing the initially transfected cells showed no sign of
IBV infection, as judged by CPE formation and Western blot analysis
(data not shown), suggesting that no infectious virus could be rescued
from these mutant transcripts. These results indicate that Y87A and
G98Dmutations may abolish the infectivity of the in vitro synthesized
full-length IBV transcripts.
As the C-terminal domain may play an essential role in dimeriza-
tion of nsp9 protein and dimerizationwas thought to be critical for its
RNA binding activity, the effects of mutations in the C-terminal region
were ﬁrstly characterized in the following studies.
Characterization of the phenotypic and growth properties of the rescued
I95A, I95N and G98A mutant viruses, and analysis of negative-strand
RNA replication and subgenomic RNA transcription in cells transfected
with G98D mutant transcripts
The growth properties of I95A, I95N and G98A mutant viruses on
Vero cells were tested by analysis of plaque sizes and growth curves of
the passage 3 mutant viruses. As shown in Fig. 2a, very similarly sized
plaques were observed in cells infected with wild type (rIBV) and the
mutant viruses. Analysis of the growth curves of wild type andmutant
viruses demonstrated that the I95A and G98A mutant viruses
exhibited similar growth kinetics as wild type virus, reaching the
peak at 16 h post-infection (Fig. 2a). At this time point, the titers of the
two mutant viruses were approximately 2–3 fold lower than that of
wild type virus (Fig. 2a). The I95Nmutant virus grewmore slowly than
wild type virus, reaching the peak at 24 h post-infection (Fig. 2a). The
titer of this mutant virus was approximately 100 fold lower than that
of wild type virus (Fig. 2a).
As no infectious virus was recovered from cells transfected with
G98D mutant transcripts, total RNA was extracted from cells electro-
porated with wild type and mutant full-length transcripts, and RT-PCR
ampliﬁcation of negative strand RNA was performed to check if RNA
replication occurred in these transfected cells. The primer pair was
chosen so that the IBV sequence from nucleotides 14,931 to 15,600
would be ampliﬁed by the RT-PCR reaction. If replication of viral RNA
occurred, a 670 bp PCR fragment would be expected. As shown in Fig.
2b, RT-PCR fragments ampliﬁed from both positive (lanes 2 and 5) andnegative (lanes 3 and 6) strand RNA templateswere obtained from cells
transfected with wild type and the mutant transcripts. The amount of
negative strand RNAwas approximately one third of the positive strand
RNA (Fig. 2b). RT-PCR ampliﬁcation of subgenomic mRNAs was then
carried out to check whether a low level of subgenomic mRNA
transcription occurred in cells transfected with the mutant transcripts.
The forward primer used in this reaction corresponds to the leader
sequence from nucleotides 26–46 in the genomic RNA and the
downstream primers covers IBV sequences from nucleotides 24,784
to 24,803. If transcription of subgenomicmRNAs did occur, a 415 bp PCR
product corresponding to the 5′-terminal region of the subgenomic
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region of the subgenomic mRNA3 would be expected. As shown in Fig.
2b, a dominant 415 bp band and aweak 1010 bp bandwere observed in
cells electroporated with wild type full-length transcripts at two days
post-electroporation (lane 4). However, the same PCR products were
not detected in cells electroporated with the mutant transcripts at 72 h
post-electroporation (Fig. 2b, lane 7).
Destabilization of the IBV nsp9 homodimer by introducing point
mutations into the C-terminal region correlating with the defect of I95N
and G98D mutant constructs in viral RNA replication and infectivity
Biochemical analysis of the effect of I95A, I95N, G98A and G98D
mutations on the dimerization and RNA-binding activity of the IBV
nsp9 was then carried out to understand the detailed mechanisms of
these point mutations on the replication and infectivity of IBV. For
this purpose, wild type and mutant fragments with a 6-His tag at
their N-terminus were cloned into a bacterial expression vector,
expressed in E. coli and puriﬁed to near homogeneity. After removing
the 6-His tag, the puriﬁed proteins were treated with 0–2% of
glutaraldehyde, a short self-polymerizing reagent that reacts with
lysine, tyrosine, histidine and tryptophan residues, and analyzed by
SDS-PAGE. Gradually increased detection of the homodimer was
observed following cross-linking of wild type and mutant proteins
with increasing concentrations of the cross-linking agent (Fig. 3a).
Interestingly, it was noted that G98D mutant protein showed much
less, if any, dimer formation without cross-linking with glutaral-
dehyde (Fig. 3a). The I95N mutant protein also showed signiﬁcantly
reduced dimer formation under the same conditions (Fig. 3a). TheseFig. 3. Biochemical characterization of the dimerization of wild type, I95A, I95N, G98A and G
G98A and G98D mutant IBV nsp9 protein after chemical cross-linking. The puriﬁed wild typ
SDS-15% polyacrylamide gel. The monomeric (m) and dimeric (d) forms of the protein are ind
type and I95N and G98D mutant nsp9 proteins by gel-ﬁltration. The puriﬁed wild type and m
column (7.8×300 mm, Waters) on Shimadszu chromatograph (LC-10ATvp) equipped with a
1 ml/min with PBS buffer at room temperature. The protein samples (300 μl) were injected
(∼24 kDa), and the second peak indicated the monomer (∼12 kDa). (c) Analysis of the dime
HeLa cells overexpressing the Flag-tagged wild type, Myc-tagged wild type and mutant nsp
lysed, separated on SDS-15% polyacrylamide gel and analyzed by Western blotting with anti
antibody, separated on SDS-15% polyacrylamide gel and analyzed by Western blotting withresults suggest that the I95N and G98D mutations may destabilize
the IBV nsp9 homodimer.
This possibility was further studied in the following two ways.
First, the puriﬁed wild type and mutant proteins were analyzed by
gel ﬁltration after removing the 6-His tag. The results showed the
detection of two peaks for wild type and the I95N mutant (Fig. 3b).
Analysis of the two peaks by mass spectrometry conﬁrmed that they
indeed represent the nsp9 monomers and dimers, respectively.
However, only one peak was observed for the G98D mutant protein
(Fig. 3b). Once again, analysis by mass spectrometry conﬁrmed that
it represents the nsp9 monomers containing the right point
mutation. Second, wild type, I95N and G98D mutant nsp9 were
cloned into a mammalian expression vector with either a Flag or a
Myc tag at the N-terminus. The Flag-tagged wild type nsp9 were co-
expressed with the Myc-tagged wild type nsp9, I95N and G98D
mutants, respectively. The association of wild type nsp9 protein with
either wild type or mutant nsp9 proteins was analyzed by
coimmunoprecipitation experiment with anti-Flag antibody. The
immunoprecipitated proteins were separated on SDS-PAGE and
analyzed by Western blotting with either anti-Flag or anti-Myc
antibody. As shown in Fig. 3c, Western blot analysis of total cell
lysates showed the detection of similar amounts of wild type and
mutant nsp9 proteins either expressed on their own or co-expressed
with the Flag-tagged wild type nsp9 (Fig. 3c, top panel). Analysis of
the precipitates with anti-Flag antibody showed the presence of
approximately equal amounts of the Flag-tagged wild type nsp9
either expressed on its own or co-expressed with the Myc-tagged
wild type and mutant nsp9 (Fig. 3c, middle panel). Analysis of the
same precipitates with anti-Myc antibody showed that efﬁcient98D mutant IBV nsp9 protein. (a) Analysis of dimerization of wild type and I95A, I95N,
e and mutant nsp9 proteins were treated with 0–2% of glutaraldehyde, and analyzed by
icated. Numbers on the left indicate molecular masses in kiloDalton. (b) Analysis of wild
utant nsp9 proteins were analyzed by gel ﬁltration assay using BioSuiteTM 250 HR SEC
photodiode array detector (SPD-M20A). The column was equilibrated at a ﬂow rate of
at a given concentration and detected. The ﬁrst peak was formed by the nsp9 dimer
rization of wild type and I95N and G98D mutant proteins by co-immunoprecipitation.
9 protein either on their own (lanes 1–4) or in different combination (lanes 5–7) were
-Myc antibody (top panels). The same lysates were immunoprecipitated with anti-Flag
either anti-Flag (middle panel) or anti-Myc (bottom panel) antibodies.
Fig. 4. Analysis of the RNA-binding activity of wild type and I95A, I95N, G98A and G98D
mutant IBV nsp9 proteins. (a) Northwestern analysis of the RNA binding activity of wild
type and I95A, I95N, G98A and G98D mutant nsp9 proteins. The puriﬁed wild type and
mutant nsp9 proteins with or without the 6xHis tag were separated on two SDS-15%
polyacrylamide gels. One gel was directly detected by staining with Commassie blue
(top panel), and the second was transferred to Hybond C extra membrane. The RNA-
binding activity was probed with either positive (middle panel) or negative (bottom
panel) sense, digoxin-labeled RNA corresponding to 26,539–27,608 nucleotides of the
IBV genome. The bands corresponding to the dimeric form with the His tag (d-His), the
dimeric formwithout the His tag (d), the monomeric formwith His tag (m-His) and the
monomeric form without the His tag (m) are indicated. Numbers on the left indicate
molecular masses in kiloDalton. (b) The relative binding activities of wild type and I95A,
I95N, G98A and G98D mutant nsp9 proteins to either positive or negative sense probes
were quantiﬁed by densitometry measurement of individual bands in three
independent Northwestern blot experiments, as shown above. The binding activity of
wild type nsp9 protein to both probes was treated as 100%.
332 B. Chen et al. / Virology 383 (2009) 328–337detection of the Myc-tagged wild type nsp9 was made only when it
was co-expressed with the Flag-tagged nsp9 protein (Fig. 3c, bottom
panel, lane 5). Interestingly, much reduced detection of the Myc-
tagged I95N was observed when it was co-expressed with the Flag-
tagged wild type nsp9 (Fig. 3c, bottom panel, lane 6), demonstrating
that this point mutation destabilizes the nsp9 homodimer. When the
Myc-tagged G98D construct was co-expressed with the Flag-tagged
wild type nsp9, the mutant protein was not detected in the co-
immunoprecipitation experiment (Fig. 3c, bottom panel, lane 7).
Taken together, these results conﬁrm that the G98D mutation totally
abolishes the nsp9 homodimer formation.
Analysis of the effect of point mutations in the C-terminal region on the
RNA-binding activity of IBV nsp9 protein
The effect of these mutations on the single strand RNA-binding
activity of IBV nsp9 was then investigated by Northwestern blotting.
Approximately equal amounts of the puriﬁed wild type and G98D
mutant proteins were separated on SDS-PAGE either before or after
removal of the 6-His tag (Fig. 4a, top panel). Once again, formation of
reasonable amounts of dimer was detected in the puriﬁed wild type
protein (Fig. 4a, top panel, lane 3). After transfer to a Hybond C extra
membrane, the RNA-binding activities of wild type and G98D mutant
proteins were analyzed by Northwestern blot with two probes
corresponding, respectively, to the positive- and negative-sense 3′-
UTR of IBV. The results showed that both wild type and G98D mutant
proteins with the 6-His tag could efﬁciently bind to either probe (Fig.
4a, middle and bottom panels, lanes 1 and 2). It was noted that
efﬁcient detection of the dimeric form of the two proteins was
achieved when either probe was used (Fig. 4a, middle and bottom
panels, lanes 1 and 2), suggesting preferential binding of the probes to
the homodimer of the protein. After removal of the 6-His tag, both the
monomeric and dimeric forms of the puriﬁed wild type protein could
still efﬁciently bind to either probe (Fig. 4a, middle and bottom panels,
lane 3). However, very weak, if any, binding of the G98D mutant
protein to either probe was observed after removal of the 6-His tag
(Fig. 4a, middle and bottom panels, lane 4), suggesting that this point
mutation abolishes the RNA-binding activity of IBV nsp9 protein. The
other three mutant proteins showed similar RNA-binding activity as
wild type protein, except that G98A mutant showed greatly reduced
binding activity to the negative RNA probe (Fig. 4a, lane 7). The
binding efﬁciency of wild type and the four mutant proteins was then
quantiﬁed by densitometry measurement of bands from three
independent experiments. The relative RNA-binding efﬁciencies of
the mutant proteins to wild type protein are shown in Fig. 4b. The
results demonstrated that the G98Dmutant protein maintained 0 and
4% binding efﬁciencies, and the G98A mutant showed 75 and 10%
binding efﬁciencies to the positive and negative probes, respectively
(Fig. 4b). The I95A and I95N mutant proteins showed 80 to 100%
binding efﬁciencies to both probes (Fig. 4b).
Biochemical and functional characterization of the effects of K10A, Y31A,
K51A, Y87A and K90A mutations on dimerization and RNA-binding
activity of IBV nsp9 protein
Biochemical characterization of the effects of other ﬁve mutations
(K10A, Y31A, K51A, Y87A and K90A) on the dimerization and RNA-
binding activity of IBV nsp9 protein was then carried out. The K10A,
Y31A, K51A and K90A mutant proteins were successfully expressed in
bacteria and puriﬁed to near homogeneity. Efforts were made to
express the Y87A mutant protein in the same system. However, very
low, if any, expression of the mutant protein was consistently
observed for some unknown reasons (data not shown). This mutant
construct was not included in the subsequent studies. After removing
the 6-His tag, the puriﬁed proteins were treated with 0–2% of
glutaraldehyde and analyzed by SDS-PAGE, showing graduallyincreased detection of the homodimer following cross-linking of
wild type and mutant proteins with increasing concentrations of the
cross-linking agent (Fig. 5a). Analysis of the puriﬁed proteins by gel
ﬁltration showed the presence of two peaks for wild type and the
mutant proteins (Fig. 5a).
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then analyzed by Northwestern blot in three independent experi-
ments. As a representative gel shown in Fig. 5b, the K10A and K90A
mutations greatly reduced the RNA-binding activity to either probe
(lanes 2 and 5). The K51Amutant protein showedmoderately reducedFig. 5. Biochemical and functional analysis of the effects of K10A, Y31A, K51A and K90Amutat
properties of the recovered mutant viruses. (a) Analysis of dimerization of wild type mutant
panels). The puriﬁed wild type and mutant nsp9 proteins were treated with 0–2% of glutaral
(d) forms of the protein are indicated. Numbers on the left indicate molecular masses in k
ﬁltration assay using BioSuiteTM 250 HR SEC column (7.8×300mm,Waters) on Shimadszu ch
columnwas equilibrated at a ﬂow rate of 1 ml/min with PBS buffer at room temperature. The
peak was formed by the nsp9s dimer (∼24 kDa), and the second peak the monomer (∼12 k
Northwestern analysis of the RNA binding activity of wild type and K10A, Y31A, K51A and K9
6xHis tag were separated on two SDS-15% polyacrylamide gels. One gel was directly dete
transferred to Hybond C extra membrane. The RNA-binding activity was probed with eith
digoxin-labeled RNA corresponding to 26,539–27,608 nucleotides of the IBV genome. The ba
without the His tag (m) are indicated. Numbers on the left indicate molecular masses in kil
positive or negative sense probes were quantiﬁed by densitometry measurement of individ
column). The binding activity of wild type nsp9 protein to both probeswas treated as 100%. (c
K51A and K90A mutant viruses. Monolayers of Vero cells on a 6-well plate were infecte
carboxymethy cellulose at 37 °C for 3 days. The cells were ﬁxed and stained with 0.1% tolui
viruses, and harvested at 0, 4, 8, 12, 16, 24, 30 and 36 h post-inoculation, respectively. Viral sto
stock was determined by infecting ﬁve wells of Vero cells on 96-well plates in triplicate wibinding activity (Fig. 5b, lane 4), and the Y31A mutant protein showed
marginally reduced binding activity (Fig. 5b, lanes 3 and 6).
Quantiﬁcation by densitometry measurement of bands from three
independent experiments showed that the K10A and K90A mutants
maintained approximately 10% binding efﬁciency to either probe, theions on dimerization and RNA-binding activity of IBV nsp9 protein as well as the growth
IBV nsp9 protein after chemical cross-linking (upper panels) and by gel-ﬁltration (lower
dehyde, and analyzed by SDS-15% polyacrylamide gel. The monomeric (m) and dimeric
iloDalton. The puriﬁed wild type and mutant nsp9 proteins were also analyzed by gel
romatograph (LC-10ATvp) equipped with a photodiode array detector (SPD-M20A). The
protein samples (300 μl) were injected at a given concentration and detected. The ﬁrst
Da). (b) Analysis of the RNA-binding activity of wild type and mutant IBV nsp9 protein.
0A mutant nsp9 proteins. The puriﬁed wild type and mutant nsp9 proteins without the
cted by staining with Commassie blue (left column, top panel), and the second was
er positive (left column, middle panel) or negative (left column, bottom panel) sense,
nds corresponding to the dimeric formwithout the His tag (d) and the monomeric form
oDalton. The relative binding activities of wild type and mutant nsp9 protein to either
ual bands in three independent Northwestern blot experiments, as shown above (right
) Plaque sizes (top panels) and growth curves (lower panel) of wild type and K10A, Y31A,
d with 100 μl of 1000-fold diluted virus stock and cultured in the presence of 0.5%
dine. Vero cells were infected with wild type and K10A, Y31A, K51A and K90A mutant
cks were prepared by freezing/thawing of the cells three times and TCID50 of each viral
th 10-fold serial dilution of each viral stock.
Fig. 5 (continued).
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the positive and negative probes, respectively, and the Y31A and I95N
mutant proteins 80 to 100% binding efﬁciencies to both probes (Fig.
5c).
The growth properties of the recovered K10A, Y31A, K51A and
K90A mutant viruses on Vero cells were tested by analysis of plaque
sizes and growth curves of the passage 3 mutant viruses. As shown in
Fig. 6c, very similarly sized plaques were observed in cells infectedFig. 6. Structural model of IBV nsp9 protein. The ribbon representation of IBV and SARS-C
modeling.with wild type (rIBV) and Y31A and K51A mutant viruses. In cells
infected with K10A and K90A and mutant viruses, plaques with
slightly smaller size were observed (Fig. 5c). Analysis of the growth
curves of wild type and mutant viruses demonstrated that the Y31A
and K51A exhibited similar growth kinetics as wild type virus,
reaching the peak at 16 h post-infection (Fig. 5c). At this time point,
the titers of the two mutant viruses were approximately 5 fold lower
than that of wild type virus (Fig. 5c). The other two mutant viruses,
K10A and K90A, grew slightly more slowly than wild type virus,
reaching the peak at 24 h post-infection (Fig. 5c). The titers of these
mutant viruses were approximately 20 fold lower than that of wild
type virus (Fig. 5c).
Discussion
Coronavirus encodes two large polyproteins (1a and 1ab poly-
proteins) by the genome-length mRNA, mRNA1. It is generally believed
that the functionally active form of the coronavirus replicase proteins
would consist of 15–16 smaller, mature proteins (nsp1–nsp16) derived
by proteolytic cleavage of these two polyproteins. In this study,
systematic mutagenesis of one of these proteins, nsp9, was carried
out to study the functional roles of this protein in coronavirus RNA
replication and infectivity. Our results are consistent with structural
data that indicate that nsp9 forms homodimers, andwe have identiﬁed
residues that are essential for nsp9 function during virus replication.
Substitution of a negatively charged amino acid (Asp) for a conserved
G98 residue in the C-terminalα-helix greatly destabilized the IBV nsp9
homodimer and abolished the RNA-binding activity of the protein.
Consequently, introduction of the samemutation into the infectious IBV
clone system showed that the mutation abolished the transcription of
subgenomicRNAandno infectious virus couldbe rescued. Interestingly,
mutation of a semi-conserved Ile (I95) residue in the same region
showed minimal effect on the RNA-binding activity of the protein and
moderately destabilizing effect on the homodimer. Introduction of this
mutation into the IBV infectious clone system showed the recovery of a
mutant virus with severe growth defects, supporting that dimerization
is critical for the function of this replicase protein.
In previous structural studies, the crystal structure of SARS-CoV nsp9
crystal contains a dimer in the asymmetric unit (Fig. 6). In each
monomer, seven-β strandsandoneα-helix formacone-shapedβ-barrel
ﬂanked by the C-terminal α-helix (Fig. 6). The C-terminal α-helix has a
high content of hydrophobic residues, yielding two hydrophobic sides.oV nsp9 protein is shown. The IBV nsp9 structure was presented based on structural
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α-helixof the secondcrystallographicmonomer to form thehomodimer
(Fig. 6). This homodimer is therefore assembled by hydrophobic
interactions (Egloff et al., 2004; Sutton et al., 2004). Analysis of the
puriﬁed SARS-CoV nsp9 protein by surface plasmon resonance
demonstrated that it is a single strand RNA-binding protein (Egloff
et al., 2004). This single strand RNA-binding activity was further
conﬁrmed by ﬂuorescence experiments (Egloff et al., 2004). By
structural modeling, the IBV nsp9 protein was found to adopt a very
similar folding as the SARS-CoV nsp9 protein (Fig. 6). Based on these
structural studies, the topology of nsp9 protein was shown to most
closely resemble the domains of the 3C-like proteinase (3CLpro) which
belongs to the serine proteinase superfamily (Berman et al., 2000).
Structure alignments revealed that it best matches to the domain II of
the coronavirus 3CLpro and subdomian I of the picornaviral 3Cpro,
suggesting that the two groups of proteins may share certain
evolutionary relationship and may play some regulatory functions
(Sutton et al., 2004). The direct correlation of the RNA replication
efﬁciency and infectivity of IBV with the stability of the nsp9
homodimer conﬁrms that dimer is the functional form of the protein.
Interestingly, the functionally active unit of the coronavirus 3CLpro is
also a dimeric form of the protein (Anand et al., 2003).
A recent study by Ponnusamyet al. (2008) reported that HCoV-229E
nsp9 forms a different homodimer from SARS-CoV nsp9, in spite of a
sequence identity of 45% between the two proteins. In HCoV-229E
nsp9, dimerization is mediated by a disulﬁde bridge, a few hydrogen
bonds, and hydrophobic interaction between the C-terminal helix of
each monomer. The structural difference between HCoV-229E and
SARS-CoV nsp9 may be due to the presence of extra residues from the
cloning procedure at theN-terminus of the SARS-CoV nsp9 preparation
used for structure determination, which could result in different
homodimer forms and different biological functions of proteins. In this
study, we observed that the six His-tags in the N-terminus of IBV Nsp9
rendered drastic effects on dimerization and RNA-binding activity of
the protein. The six-His tagwas removed by factor Xa fromallwild type
and mutant constructs in our biochemical studies of the protein.
HCoV-229E nsp9 has a Cys (Cys 69) residue in the alpha helix at the
homodimer interface and forms a disulﬁde bridge. This form of nsp9
dimer can bind to single-stranded RNA more tightly and therefore
promote replication of the viral genome (Ponnusamy et al. 2008). The
SARS-CoV nsp9 has three Cys residues and one of them (Cys 73) is
corresponding to Cys 69 in HCoV-229E nsp9. However, these residues
are not involved in the formation of intermolecular disulﬁde bond
(Ponnusamy et al. 2008). As the number and position of Cys residues
in IBV nsp9 are completely conserved with SARS-CoV nsp9, the IBV
nsp9may form dimer mainly through hydrophobic interaction similar
to SARS-CoV nsp9 rather than through formation of a disulﬁde bridge.
It is intriguing that mutation of the G98 residue to an Asp totally
blocks the dimerization and RNA-binding activity of the protein. As
explained, no infectious virus was recovered from cells transfected
with G98D mutant transcripts. Evidence present suggests that G98D
mutation may lead to the disruption of subgenomic RNA transcription
and the protein is therefore directly involved in the viral replication.
As the RNA-binding assay used in this study involves binding of RNA
probes to the denatured, momomeric form of the nsp9 protein, it is
quite unlikely that the loss of RNA-binding activity for this mutant is
the direct consequence of destabilization of the nsp9 homodimer by
this point mutation. One possibility is that the C-terminal domain is
directly involved in the binding of RNA. Alternatively, this point
mutation may alter the overall folding of the protein.
Nsp9 protein is a nucleic acid-binding protein. The structural
characteristics of nsp9 suggested that its nucleic acid-binding activity
is not strictly sequence-speciﬁc (Egloff et al., 2004; Sutton et al., 2004).
The nsp9 protein may bind RNA through wrapping of the ssRNA
around the nsp9 dimer (Egloff et al., 2004; Sutton et al., 2004). In this
study, we show that mutations of some positively charged residues inthe β-barrel regions could signiﬁcantly reduce the RNA-binding
activity of the protein. However, introduction of the same mutations
into the viral genome showed only mild or moderate effects on the
growth and infectivity of the rescued mutant viruses, though positive
correlation between the lowered binding activity and the reduced
infectivity of the mutant viruses was observed. It seems that
mutations that destabilized the nsp9 homodimer render more
profound effect on IBV infectivity than mutations that reduced the
RNA-binding activity of the protein per se. We are currently uncertain
if this may reﬂect the limitation of the assay used to analyze the RNA-
binding activity of the protein in the study. On the other hand, it would
suggest that formation of the nsp9 homodimermay play functions not
directly related to the RNA-binding activity of the protein. One
possibility is that dimerization of the protein may facilitate its
interaction with other viral replicase proteins or host cell proteins
involved in the viral replication cycle.
Nsp9 is a putative component of the replication complex. In cells
infected with MHV, nsp9 is localized in the perinuclear region
together with other proteins of the replication complex (Bost et al.,
2000). RdRp was shown to coimmunoprecipitate with 3CLpro, nsp8
and nsp9 (Brockway et al., 2003). Biophysical evidence has also been
presented for an interaction between nsp9 and nsp8 of MHV (Sutton
et al., 2004). Interaction between other replicase proteins was also
documented. For example, a co-crystal structure of SARS-CoV nsp7
with nsp8 revealed a complex of eight monomers of each protein
forming a hollow cylindrical structure. This hexadecameric assembly
was proposed to be able to encircle an RNA template, possibly acting
as a processivity factor for the RNA polymerase (Zhai et al., 2005).
Structural analysis indicated that nsp9 may play multiple roles in
coronavirus replication cycle, and its interaction with other proteins
may be essential for the formation of the viral replication complex
together with its ability to interact with RNA (Egloff et al., 2004;
Sutton et al., 2004). However, we were unable to demonstrate direct
interaction between IBV nsp9 and the two putative essential
components of the replication complex, RdRp and RNA helicase in
the overexpression system (data not shown). It suggests that
formation of the replication complex may involve other viral and
host cell components, including the viral RNA template. Further study
would be required to address this interesting issue.
Materials and methods
Cells and cell culture
HeLa and Vero cells were cultured in complete Dulbecco's
modiﬁed Eagle's medium (Invitrogen) supplemented with 10% new-
born calf serum (Sterile) and 1% penicillin (Invitrogen) andmaintained
at 37 °C in 5% CO2.
Transient expression of viral protein in mammalian cells
Wild type and mutant IBV nsp9 sequences were placed under the
control of a T7 promoter and transiently expressed in mammalian
cells using a vaccinia virus-T7 system. Brieﬂy, semiconﬂuent mono-
layers of HeLa cells were infectedwith 10 plaque forming units/cells of
recombinant vaccinia virus (vTF7-3), which expresses the T7 RNA
polymerase gene, for 2 h at 37 °C prior to transfection. The plasmid
DNA was transfected into vTF7-3-infected cells using Effectene
transfection reagent according to the manufacturer's instructions
(Qiagen). Cells were harvested at 12 to 24 h post-transfection.
Expression, puriﬁcation and characterization of IBV nsp9 protein in E. coli
His-tagged wild type and mutant nsp9 proteins were expressed in
E. coli BL-21 by induction with 1 mM isopropyl-b-D-thiogalacto-
pyranoside (IPTG). Cells were lysed by sonication, puriﬁed by metal
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The puriﬁed nsp9-His fusion protein was digested with Factor Xa
(Qiagen) overnight at 25 °C with 1.0 U/40 μl of Factor Xa to the puriﬁed
fusion protein in reaction buffer containing 20 mM Tris–Cl, pH 6.5;
50 mM NaCl; 1 mM CaCl2. After digestion, Factor Xa was removed by
afﬁnity chromatography with Xa Removal Resin (Qiagen). Any
uncleaved His tag fusion protein remaining after 24 h of digestion
was removed by rebinding the sample to Protino-Ni105 column
(Macherey Nagel).
Co-immunoprecipitation
Transiently transfected HeLa cells in 60-mm dishes were lysed in
1 ml of lysis buffer (150 mM NaCl, 1% NP-40, and 50 mM Tris–HCl, pH
8.0) with 0.5% protease inhibitor cocktail (Sigma). The lysates were
centrifuged at 12,000 rpm for 30 min at 4 °C. The supernatants were
added with anti-Flag (Biomed Diagnostics) antibodies at 4 °C for 2 h.
Protein-A agarose beads (30 μl) (KPL) were added to the lysates and
incubated with shaking for 1 h at 4 °C. The beads were collected by
centrifugation and washed for three times with RIPA buffer (150 mM
NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.05% SDS, and 50 mM
Tris–HCl, pH 8.0). Proteins binding to the beads were eluted by adding
2×SDS loading buffer and analyzed byWestern blotting with anti-Flag
or anti-Myc antibody.
Northwestern blot
PCR fragments covering the IBV genome from 27,100 to 27,608
nucleotides were cloned into a plasmid pGEM in either forward or
reverse orientation under the control of a T7 promoter. The Dig-labeled
sense (+) and anti-sense (−) RNA probes were made in vitro using the
DIG RNA labeling kit according to the instructions of the manufacturer
(Roche).
Three micrograms of puriﬁed proteins was resolved on an SDS-15%
polyacrylamide gel and transferred onto nitrocellulose membranes
(Hybond C-Extra, Amersham Biosciences) using a semi-dry transfer
apparatus. Membranes were washed for 10 min with the probe
buffer (1×Denhardt's Reagent, 1 mM EDTA, 10 mM Tris–HCl (pH 7.5)
and 50 mM NaCl), blocked for 1 h with 25 mg/ml yeast tRNA
(Ambion) and subsequently incubated with 10 mg of DIG-labeled
RNA probe in the same probe buffer for 1 h. Membranes were
washed three times for 15 min each with the probe buffer, before
proceeding to detection with CDP-Star (Roche) according to the
manufacturer's instructions.
Chemical cross-linking assay
To investigate the multimeric features of nsp9 protein, the
chemical cross-linking experiment was carried out. Wild type and
mutate nsp9 protein were puriﬁed by gel ﬁltration column and
digested by DNAase and RNAase to get rid of the possible binding
nucleic acids. Glutaraldehyde (25%, Sigma) was diluted to a series of
concentrations (2%, 4%, 8%, 10%, 20%) by distilled water. The protein in
PBS buffer was reacted with glutaraldehyde at 16 °C for 30 min. The
reactionwas stopped by adding SDS PAGE loading buffer and heated at
100 °C for 10 min.
Size-exclusion chromatography assay
The gel-ﬁltration assay was performed for further investigating
nsp9 protein multimeric features using BioSuite™ 250 HR SEC column
(7.8×300 mm, Waters) on Shimadszu chromatograph (LC-10ATvp)
equipped with a photodiode array detector (SPD-M20A). The column
was equilibrated at a ﬂow rate of 1 ml/min with PBS buffer at room
temperature. The protein sample (300 μl) was injected at a given
concentration and detected.Construction of an infectious IBV clone, introduction of mutations into
the clones and rescue of recombinant viruses
Construction of an infectious IBV clone was carried out as
described (Tan et al., 2006; Fang et al., 2007). Brieﬂy, ﬁve fragments
spanning the entire IBV genome were obtained by RT-PCR from Vero
cells infected with the Vero cell-adapted IBV p65. The PCR products
were puriﬁed from agarose gels and cloned into pCR-XL-TOPO
(Invitrogen) or pGEM-T Easy (Promega) vectors. Subsequently,
fragment A was removed from pCR-XL-TOPO by digestion with NheI
and EcoRI, and subcloned into pKT0 vector. Plasmids were digested
with either BsmBI (fragment A) or BsaI (fragments B, C, D and E). The
digested plasmids were separated on 0.8% agarose gels containing
crystal violet. Bands corresponding to each of the fragments were cut
from the gels and puriﬁed with QIAquick gel extraction kit (QIAGEN
Inc.). Fragments A and B, and fragments C, D and E were ﬁrst ligated
with T4 DNA ligase at 4 °C overnight. The two reaction mixtures were
then mixed and further ligated at 4 °C overnight. The ﬁnal ligation
products were extracted with phenol/chloroform/isoamyl alcohol
(25:24:1), precipitated with ethanol and detected by electrophoresis
on 0.4% agarose gels. Full-length transcripts were generated in vitro
using the mMessage mMachine T7 kit (Ambion, Austin, TX). The N
transcriptswere generated by using a linearized pKTO-IBVNcontaining
IBVNgene and the 3′-untranslated region (3′-UTR) as templates. The in
vitro synthesized full-length and N transcripts were treated with
DNase I and puriﬁedwith phenol/chloroform. Vero cellswere grown to
90% conﬂuence, trypsinized, washed twice with cold phosphate-
buffered saline (PBS), and resuspended in PBS. RNA transcripts were
added to 400 μl of Vero cell suspension in an electroporation cuvette,
and electroporated with one pulse at 450 V, 50 μF with a Bio-Rad Gene
Pulser II electroporator. The transfected Vero cells were cultured
overnight in 1% FBS-containing MEM in a 60mm dish or a 6-well plate
and further cultured in MEMwithout FBS. Mutations were introduced
into the corresponding fragments by using QuickChange site-directed
mutagenesis kit (Stratagene), and conﬁrmed by sequencing of the
whole fragments.
Growth curve and plaque sizes of the recombinant viruses on Vero cells
Conﬂuent monolayers of Vero cells on 6-well plates were infected
with wild-type and mutant viruses at a multiplicity of ∼1 PFU/cell.
After 1 h of incubation at 37 °C, cells were washed twice with PBS and
cultured in 3 ml of MEM containing 0.5% carboxymethy cellulose for
3 days. The cells were ﬁxed and stained with 0.1% toluidine.
Vero cells were infected with wild-type and recombinant IBV, and
harvested at different times post-infection. Viral stocks were prepared
by freezing/thawing of the cells three times. The plaque-forming units
perml of each samplewere determinedby infectingVero cells on6-well
plates in duplicate with 10-fold serial dilution of each viral stock.
Structure predication of IBV nsp9
JIGSAW server, MOLMOL and PYMOL viewer were used to predict
the tertiary structure of IBV nsp9.
Construction of plasmids
PCR products covering the IBV sequence from 11,542 to 11,880
nucleotides were ampliﬁed by using the forward primer 5′-
CGCGGATCCAATAATGAGCTTATGCCA-3′ and the reverse primer 5′-
CCGCTCGAGCTAAGACTGTAAGACAAC-3′. The PCR fragments were
digested with BamHI and XhoI, and ligated into BamHI and XhoI
digested pXL40 to form plasmid pXL-nsp9. For the plasmid pET-nsp9,
the IBV sequence from 11,542 to 11,880 nucleotides was ampliﬁed by
using the forward primer 5′-GGGAATTCCATATGAATAATGAGCT-
TATGCCA-3′ and the reverse primer 5′-CGCGGATCCTTAAGACTGTAA-
337B. Chen et al. / Virology 383 (2009) 328–337GACAACAAC-3′. The PCR fragments were digested with NdeI and
BamHI, and ligated into plasmid pET-16 which was digested by NdeI
and BamHI, to form plasmid pET-nsp9. Each mutationwas introduced
by two rounds of PCR and the mutation introduced was conﬁrmed by
automated nucleotide sequencing.
References
Anand, K., Palm, G.J., Mesters, J.R., Siddell, S.G., Ziebuhr, J., Hilgenfeld, R., 2002. Structure
of coronavirus main proteinase reveals combination of a chymotrypsin fold with an
extra alpha-helical domain. EMBO J. 21, 3213–3224.
Anand, K., Ziebuhr, J., Wadhwani, P., Mesters, J.R., Hilgenfeld, R., 2003. Coronavirus main
proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science 300,
1763–1767.
Berman, H.M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T.N., Weissig, H., Shindyalov, I.N.,
Bourne, P.E., 2000. The Protein Data Bank. Nucleic Acids Res. 28, 235–242.
Bost, A.G., Carnahan, R.H., Tao Lu, X., Denison, M.R., 2000. Four proteins processed from
the replicase gene polyprotein of mouse hepatitis virus colocalize in the cell
periphery and adjacent to sites of virion assembly. J. Virol. 74, 3379–3387.
Boursnell, M.E.G., Brown, T.D.K., Foulds, I.J., Green, P.F., Tomley, F.M., Binns, M.M., 1987.
Completion of the sequence of the genome of the coronavirus avian infectious
bronchitis virus. J. Gen. Virol. 68, 57–77.
Brockway, S.M., Clay, C.T., Lu, X.T., Denison, M.R., 2003. Characterization of the
expression, intracellular localization, and replication complex associated with the
putative mouse hepatitis virus RNA-dependent RNA polymerase. J. Virol. 77,
10515–10527.
Egloff, M-P., Ferron, F., Campanacci, V., Longhi, S., Rancurel, C., Dutartre, H., Snijder, E.J.,
Gorbalenya, A.E., Cambillau, C., Canard, B., 2004. The severe acute respiratory
syndrome coronavirus replicative protein nsp9 is a single-stranded RNA-binding
subunit unique in the RNA virus world. Proc. Natl. Acad. Sci. U. S. A. 101, 3792–3796.
Fang, S.G., Chen, B., Tay, F.P.L., Liu, D.X., 2007. An arginine-to-prolinemutation in a domain
with undeﬁned function within the RNA helicase protein (NSP13) is lethal to the
coronavirus infectious bronchitis virus in cultured cells. Virology 358, 136–147.
Gosert, R., Kanjanahaluethai, A., Egger, D., Bienz, K., Baker, S.C., 2002. RNA replication of
mouse hepatitis virus takes place at double-membrane vesicles. J. Virol. 76,
3697–3708.
Imbert, I., Guillemot, J.C., Bourhis, J.M., Bussetta, C., Coutard, B., Egloff, M.P., Ferron, F.,
Gorbalenya, A.E., Canard, B., 2006. A second, non-canonical RNA-dependent RNA
polymerase in SARS coronavirus. EMBO J. 25, 4933–4942.
Joseph, J.S., Saikatendu, K.S., Subramanian, V., Neuman, B.W., Brooun, A., Grifﬁth, M.,
Moy, K., Yadav, M.K., Velasquez, J., Buchmeier, M.J., Stevens, R.C., Kuhn, P., 2006.
Crystal structure of nonstructural protein 10 from the SARS coronavirus reveals a
novel fold with two zinc-binding motifs. J. Virol. 80, 7894–7901.
Lim, K.P., Liu, D.X., 1998a. Characterization of a papain-like proteinase domain encoded
by ORF1a of the coronavirus IBV and determination of the C-terminal cleavage site
of an 87 kDa protein. Adv. Exp. Med. Biol. 440, 173–184.
Lim, K.P., Liu, D.X., 1998b. Characterization of the two overlapping papainlike proteinase
domains encoded in gene 1 of the coronavirus infectious bronchitis virus and
determination of the C-terminal cleavage site of an 87 kDa protein. Virology 245,
303–312.
Lim, K.P., Ng, L.F., Liu, D.X., 2000. Identiﬁcation of a novel cleavage activity of the ﬁrst
papain-like proteinase domain encoded by open reading frame 1a of the
coronavirus avian infectious bronchitis virus and characterization of the cleavage
products. J. Virol. 74, 1674–1685.
Liu, D.X., Tibbles, K.W., Cavanagh, D., Brown, T.D.K., Brierley, I., 1995. Identiﬁcation,
expression and processing of an 87K polypeptide encoded by ORF1a of the
coronavirus infectious bronchitis virus. Virology 208, 47–54.
Liu, D.X., Xu, H.Y., Brown, T.D.K., 1997. Proteolytic processing of the coronavirus
infectious bronchitis virus 1a polyprotein: identiﬁcation of a 10 kDa polypeptide
and determination of its cleavage sites. J. Virol. 71, 1814–1820.
Liu, D.X., Shen, S., Xu, H.Y., Wang, S.F., 1998. Proteolytic mapping of the coronavirus
infectious bronchitis virus 1b polyprotein: evidence for the presence of fourcleavage sites of the 3C-like proteinase and identiﬁcation of two novel cleavage
products. Virology 246, 288–297.
Masters, P.S., 2006. The molecular biology of coronaviruses. Adv. Virus Res. 66, 193–292.
Ng, L.F., Liu, D.X., 1998. Identiﬁcation of a 24-kDa polypeptide processed from the
coronavirus infectious bronchitis virus 1a polyprotein by the 3C-like proteinase and
determination of its cleavage sites. Virology 243, 388–395.
Ng, L.F., Liu, D.X., 2000. Further characterization of the coronavirus infectious bronchitis
virus 3C-like proteinase and determination of a new cleavage site. Virology 272,
27–39.
Ng, L.F., Liu, D.X., 2002. Membrane association and dimerization of a cysteine-rich,
16-kiloDalton polypeptide released from the C-terminal region of the coronavirus
infectious bronchitis virus 1a polyprotein. J. Virol. 76, 6257–6267.
Peti, W., Johnson, M.A., Herrmann, T., Neuman, B.W., Buchmeier, M.J., Nelson, M.,
Joseph, J., Page, R., Stevens, R.C., Kuhn, P., Wu(thrich, K., 2005. Structural genomics
of the severe acute respiratory syndrome coronavirus: nuclear magnetic resonance
structure of the protein nsp7. J. Virol. 79, 12905–12913.
Ponnusamy, R., Moll, R., Weimar, T., Mesters, J.R., Hilgenfeld, R., 2008. Variable
oligomerizationmodes in coronavirus non-structural protein 9. J. Mol. Biol. 2008 Jul
30 [Electronic Publication ahead of print].
Prentice, E., Jerome, W.G., Yoshimori, T., Mizushima, N., Denison, M.R., 2004.
Coronavirus replication complex formation utilizes components of cellular
autophagy. J. Biol. Chem. 279, 10136–10141.
Ratia, K., Saikatendu, K.S., Santarsiero, B.D., Barretto, N., Baker, S.C., Stevens, R.C.,
Mesecar, A.D., 2006. Severe acute respiratory syndrome coronavirus papain-like
protease: structure of a viral deubiquitinating enzyme. Proc. Natl. Acad. Sci. U. S. A.
103, 5717–5722.
Ricagno, S., Egloff, M.P., Ulferts, R., Coutard, B., Nurizzo, D., Campanacci, V., Cambillau, C.,
Ziebuhr, J., Canard, B., 2006. Crystal structure and mechanistic determinants of
SARS coronavirus nonstructural protein 15 deﬁne an endoribonuclease family. Proc.
Natl. Acad. Sci. U. S. A. 103, 11892–11897.
Saikatendu, K.S., Joseph, J.S., Subramanian, V., Clayton, T., Grifﬁth,M.,Moy, K., Velasquez, J.,
Neuman, B.W., Buchmeier, M.J., Stevens, R.C., Kuhn, P., 2005. Structural basis of severe
acute respiratory syndrome coronavirus ADP-ribose-1″-phosphate dephosphory-
lation by a conserved domain of nsp3. Structure 13, 1665–1675.
Shi, S.T., Schiller, J.J., Kanjanahaluethai, A., Baker, S.C., Oh, J.W., Lai, M.M.C., 1999.
Colocalization and membrane association of murine hepatitis virus gene 1products
and de novo-synthesized viral RNA in infected cells. J. Virol. 73, 5957–5969.
Sims, A.C., Ostermann, J., Denison, M.R., 2000. Mouse hepatitis virus replicase proteins
associate with two distinct populations of intracellular membranes. J. Virol. 74,
5647–5654.
Su, D., Lou, Z., Sun, F., Zhai, Y., Yang, H., Zhang, R., Joachimiak, A., Zhang, X.C., Bartlam, M.,
Rao, Z., 2006. Dodecameric structure of severe acute respiratory syndrome
coronavirus nonstructural protein nsp10. J. Virol. 80, 7902–7908.
Sutton, G., Fry, E., Carter, L., Sainsbury, S., Walter, T., Nettleship, J., Berrow, N., Owens, R.,
Gilbert, R., Davidson, A., Siddell, S., Poon, L.L.M., Diprose, J., Alderton, D., Walsh, M.,
Grimes, J.M., Stuart, D.I., 2004. The nsp9 replicase protein of SARS-coronavirus,
structure and functional insights. Structure 12, 341–353.
Tan, Y.W., Fang, S., Fan, H., Lescar, J., Liu, D.X., 2006. Amino acid residues critical for RNA-
binding in the N-terminal domain of the nucleocapsid protein are essential
determinants for the infectivity of coronavirus in cultured cells. Nucleic Acids Res.
34, 4816–4825.
Xu, H.Y., Lim, K.P., Shen, S., Liu, D.X., 2001. Further identiﬁcation and characterization of
novel intermediate and mature cleavage products released from the ORF 1b region
of the avian coronavirus infectious bronchitis virus 1a/1b polyprotein. Virology 288,
212–222.
Yang, H., Yang, M., Ding, Y., Liu, Y., Lou, Z., Zhou, Z., Sun, L., Mo, L., Ye, S., Pang, H., Gao, G.F.,
Anand, K., Bartlam, M., Hilgenfeld, R., Rao, Z., 2003. The crystal structures of severe
acute respiratory syndrome virus main protease and its complex with an inhibitor.
Proc. Natl. Acad. Sci. U. S. A. 100, 13190–13195.
Zhai, Y., Sun, F., Li, X., Pang, H., Xu, X., Bartlam, M., Rao, Z., 2005. Insights into SARS-CoV
transcription and replication from the structure of the nsp7–nsp8 hexadecamer.
Nat. Struct. Mol. Biol. 12, 980–986.
Ziebuhr, J., 2005. The coronavirus replicase. Curr. Top. Microbiol. Immunol. 287, 57–94.
Ziebuhr, J., Snijder, E.J., Gorbalenya, A.E., 2000. Virus-encoded proteinases and
proteolytic processing in the Nidovirales. J. Gen. Virol. 81, 853–879.
